BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31896778)

  • 1. CUGC for syndromic microphthalmia including next-generation sequencing-based approaches.
    Eintracht J; Corton M; FitzPatrick D; Moosajee M
    Eur J Hum Genet; 2020 May; 28(5):679-690. PubMed ID: 31896778
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical utility gene card for: Non-Syndromic Microphthalmia Including Next-Generation Sequencing-Based Approaches.
    Richardson R; Sowden J; Gerth-Kahlert C; Moore AT; Moosajee M
    Eur J Hum Genet; 2017 Apr; 25(4):. PubMed ID: 28098148
    [No Abstract]   [Full Text] [Related]  

  • 3. Anophthalmia including next-generation sequencing-based approaches.
    Harding P; Brooks BP; FitzPatrick D; Moosajee M
    Eur J Hum Genet; 2020 Mar; 28(3):388-398. PubMed ID: 31358957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of clinical criteria and high-throughput sequencing for diagnosing children with syndromic craniosynostosis.
    Tønne E; Due-Tønnessen BJ; Mero IL; Wiig US; Kulseth MA; Vigeland MD; Sheng Y; von der Lippe C; Tveten K; Meling TR; Helseth E; Heimdal KR
    Eur J Hum Genet; 2021 Jun; 29(6):920-929. PubMed ID: 33288889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Towards a national standardisation of NGS studies in the diagnosis of myopathies].
    Krahn M; Cerino M; Campana-Salort E; Cossée M
    Med Sci (Paris); 2017 Nov; 33 Hors série n°1():30-33. PubMed ID: 29139383
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the best candidates for next-generation sequencing-based gene panel for evaluation of early-onset epilepsy.
    Lee J; Lee C; Ki CS; Lee J
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1376. PubMed ID: 32613771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.
    Robyns T; Kuiperi C; Breckpot J; Devriendt K; Souche E; Van Cleemput J; Willems R; Nuyens D; Matthijs G; Corveleyn A
    Eur J Hum Genet; 2017 Dec; 25(12):1313-1323. PubMed ID: 29255176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
    Hong S; Wang L; Zhao D; Zhang Y; Chen Y; Tan J; Liang L; Zhu T
    Mol Genet Genomic Med; 2019 Jun; 7(6):e684. PubMed ID: 30968598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGS panel analysis in 24 ectopia lentis patients; a clinically relevant test with a high diagnostic yield.
    Overwater E; Floor K; van Beek D; de Boer K; van Dijk T; Hilhorst-Hofstee Y; Hoogeboom AJM; van Kaam KJ; van de Kamp JM; Kempers M; Krapels IPC; Kroes HY; Loeys B; Salemink S; Stumpel CTRM; Verhoeven VJM; Wijnands-van den Berg E; Cobben JM; van Tintelen JP; Weiss MM; Houweling AC; Maugeri A
    Eur J Med Genet; 2017 Sep; 60(9):465-473. PubMed ID: 28642162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield of panel-based genetic testing in syndromic inherited retinal disease.
    Jiman OA; Taylor RL; Lenassi E; Smith JC; Douzgou S; Ellingford JM; Barton S; Hardcastle C; Fletcher T; Campbell C; Ashworth J; Biswas S; Ramsden SC; ; Manson FD; Black GC
    Eur J Hum Genet; 2020 May; 28(5):576-586. PubMed ID: 31836858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
    Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
    Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility gene card for: inherited optic neuropathies including next-generation sequencing-based approaches.
    Jurkute N; Majander A; Bowman R; Votruba M; Abbs S; Acheson J; Lenaers G; Amati-Bonneau P; Moosajee M; Arno G; Yu-Wai-Man P
    Eur J Hum Genet; 2019 Mar; 27(3):494-502. PubMed ID: 30143805
    [No Abstract]   [Full Text] [Related]  

  • 15. De Novo Assembly-Based Analysis of
    Maggi J; Roberts L; Koller S; Rebello G; Berger W; Ramesar R
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32679846
    [No Abstract]   [Full Text] [Related]  

  • 16. Pitfalls in variant annotation for hereditary cancer diagnostics: The example of Illumina® VariantStudio®.
    Kalfakakou D; Konstantopoulou I; Yannoukakos D; Fostira F
    Genomics; 2021 Jan; 113(1 Pt 2):748-754. PubMed ID: 33053411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of copy number variation analysis for next-generation sequencing diagnostics.
    Ellingford JM; Campbell C; Barton S; Bhaskar S; Gupta S; Taylor RL; Sergouniotis PI; Horn B; Lamb JA; Michaelides M; Webster AR; Newman WG; Panda B; Ramsden SC; Black GC
    Eur J Hum Genet; 2017 Jun; 25(6):719-724. PubMed ID: 28378820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis.
    Fleige T; Burggraf S; Czibere L; Häring J; Glück B; Keitel LM; Landt O; Harms E; Hohenfellner K; Durner J; Röschinger W; Becker M
    Eur J Hum Genet; 2020 Feb; 28(2):193-201. PubMed ID: 31570786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing.
    Zeng Q; Leach NT; Zhou Z; Zhu H; Smith JA; Rosenblum LS; Kenyon A; Heim RA; Eisenberg M; Letovsky S; Okamoto PM
    Sci Rep; 2020 Sep; 10(1):15060. PubMed ID: 32929119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA.
    de Boer EN; van der Wouden PE; Johansson LF; van Diemen CC; Haisma HJ
    Gene Ther; 2019 Aug; 26(7-8):338-346. PubMed ID: 31296934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.